Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20190705001
TCTR20190705001
Completed
未知

Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: development and internal validation

/A0 sites217 target enrollmentJuly 5, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsContrast&#45induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score&#44contrast&#45induced nephropathy&#44STEMI

Overview

Phase
未知
Intervention
Not specified
Conditions
Contrast&#45
Sponsor
/A
Enrollment
217
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2019
End Date
June 30, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • •Acute ST segment elevated myocardial infarction patients aged more than 18 years old who were treated with primary percutaneous coronary intervention at cardiac catheterization laboratory of the institute were included from June 1, 2017 to June 30, 2018\. End\-stage renal disease patients with estimated glomerular filtration less than 15 ml/min/1\.73 m2 or being treated with peritoneal or hemodialysis.

Exclusion Criteria

  • •Patients who were exposed to contrast media agent 7 days prior to the index PCI procedure, and patients who did not survive primary PCI were excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A risk-predictive score for developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markersHealth Condition 1: K758- Other specified inflammatory liverdiseases
CTRI/2022/12/048328PG Grants, Kasturba Medical College
Recruiting
Not Applicable
Prediction of cancer-associated venous thromboembolismCancer-associated venous thromboembolism
NL-OMON23071Amsterdam UMC2,000
Recruiting
Not Applicable
The new risk scoring system for predicting epithelial ovarian malignancy: Risk of ovarian cancer score (ROCS)Adnexal massOvarian cancerAdnexal mass, Ovarian cancer, Predictive model, Risk scoring
TCTR20231103007Srinakharinwirot University124
Completed
Not Applicable
Investigation of prediction abilities for a risk of hypoglycemia of intermediate-term glycemic variability metrics using continuous glucose monitor datatype 2 diabetes
JPRN-UMIN000032899Inuyama Chuo General Hospital104
Not yet recruiting
Not Applicable
To Validate the Risk Scoring System that is developed by Madras Medical Mission, to predict whether the contrast used during the procedure of angioplasty would result in any alteration of kidney functio
CTRI/2014/10/005080The Madras Medical Mission Hospital5,000